The essential news of the week of June 13
This week’s best articles:
FDA authorizes Moderna, Pfizer-BioNTech COVID-19 vaccines for children up to 6 months
The FDA today announces the EUA of Moderna and Pfizer-BioNTech COVID-19 vaccines for use in children 6 months of age and older.
More than 300 pediatricians submit personal gun violence testimonies to Congressional record
Ahead of the US Senate Judiciary Committee hearing on gun violence prevention, the American Academy of Pediatrics announced the submission of a statement including more than 300 pediatricians sharing their personal testimonies on the topic.
Somapacitan injection once a week shows its effectiveness in children with GHD
Data from a recent study of weekly injection of somapacitan show positive results for prepubertal children with growth hormone deficiency (GHD).
FDA accepts sNDA for review of Myfembree for treatment of uterine fibroids
The FDA recently announced the acceptance of a Supplemental New Drug Application for relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
More articles from this week:
The challenges of prescribing isotretinoin
Scynexis submits an sNDA for the extension of the indication of ibrexafungerp tablets
Comparison of methods for recruiting parents of autistic children
The youth mental health crisis: supporting patients with ASD and ADHD
Prolonged stress and anxiety during pregnancy disrupting fetal brain development
A glimpse of dupilumab approval
Atopic dermatitis and infertility
WADA: Climate change is a public health crisis
FDA committee recommends Pfizer-BioNTech and Moderna COVID-19 vaccines for children 6 months and older
Reckitt Mead Johnson Receives FDA Approval to Import 66 Million Servings of Formula
WADA seeks to crack down on medical professionals spreading misinformation
An update on the presentation, nosology and causes of postpartum psychosis
Having “the conversation” with adolescent patients